What is the mechanism of action of TB-500?

Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. This influences cell migration during repair, angiogenesis, and stem-cell mobilisation. Acts systemically when injected anywhere, unlike many peptides whose effects are local. For anabolic and recovery applications specifically, the relevant downstream consequence is the cascade from receptor engagement to systemic effect: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. The body composition / training interpretation focuses on the pathway-level detail rather than on any single high-level summary.

How long until I see results from TB-500?

Acute effects from TB-500 appear within the first week for downstream physiological adaptation. anabolic and recovery endpoints accumulate across 4–8 weeks; the typical 8–12 week cycle is calibrated to allow the full response window. Single-week evaluations consistently underestimate the response trajectory.

What should I look for in TB-500 sourcing and quality?

Acceptable TB-500 certificates of analysis specify: lot-specific (not template) issuance, HPLC purity ≥98%, mass spec confirmation matching 888-1717 Da (depending on form), endotoxin testing for injectable routes, and third-party accredited laboratory issuance. Template COAs, missing endotoxin data, or vendor-internal labs are red flags. Pharmaceutical-grade compounded material is the lowest-risk supply path where accessible.

What is the regulatory status of TB-500?

TB-500 regulatory status: Unapproved in the United States; WADA status banned (s0); research level preclinical + veterinary clinical (equine). Clinical access for off-label use is via compounded prescription where permissible. International regulatory status varies by jurisdiction. For anabolic and recovery use specifically, the regulatory profile shapes which monitoring and supervision approaches are required.

How should TB-500 be stored and reconstituted?

Lyophilised TB-500 stores at −20°C for 18–24 months. After reconstitution with bacteriostatic water, the solution holds at 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Travel with cold packs in insulated containers; avoid prolonged exposure above 25°C. The standard reconstitution concentration is 1–2 mg/mL depending on the vial size.

Home/ Compounds/ TB-500

TB-500

Body Composition

Athletes and performance coaches evaluating TB-500 for body composition focus on three measurable endpoints: lean mass, recovery capacity, and the rate of return to training intensity between sessions. Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool This influences cell migration during repair, angiogenesis, and stem-cell mobilisation. Acts systemically when injected anywhere, unlike many peptides whose effects are local.. The 2-5 mg 1-2x weekly subq (loading phase); maintenance lower protocol over the standard 8-12 week cycle, paired with training stimulus and nutritional adequacy, is where the body-composition response is generated.

Body Composition / Training Applications

Cardiovascular ConditioningMuscle EnduranceEnduranceWorkout RecoveryJoint Health

Key Takeaways

Body composition lens: response to TB-500 is proportional to training stimulus and nutritional adequacy.
Mechanism: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool.
Body composition dose: 2-5 mg 1-2x weekly subq (loading phase); maintenance lower via subq/im; effects visible at week 4-8 with adequate training and protein.
Cycle structure: 8-12 weeks on, 4 weeks off; training-day or daily dosing depending on half-life.
Performance stack partners: IGF-1 LR3, CJC-1295 + Ipamorelin Blend, BPC-157.

Body Composition / Training Mechanism

Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. This influences cell migration during repair, angiogenesis, and stem-cell mobilisation. Acts systemically when injected anywhere, unlike many peptides whose effects are local. Body composition relevance of this mechanism depends on which dimension of the anabolic cascade TB-500 engages: direct GH/IGF-axis activation, recovery-and-connective-tissue effects, or training-adjacent (sleep, inflammation) layers. The subsections below cover anabolic substrate, recovery window, training-day dosing, and hyperplasia versus hypertrophy.

Anabolic substrate and protein synthesis

TB-500's relevance to body composition depends on where in the anabolic cascade it acts. It acts on adjacent rather than directly anabolic pathways, but the contribution to recovery, connective tissue, and inflammatory tone produces measurable body-composition effects in trained users. The downstream effect on body composition is dose- and training-dependent.

Hyperplasia and structural adaptation

Where TB-500 demonstrates effects on fibre count rather than fibre size — hyperplasia rather than hypertrophy — the structural adaptation matters more than the acute anabolic signal. Most peptides in this category contribute to the hypertrophic rather than hyperplastic adaptation, with the magnitude depending on training stimulus.

Training-day versus rest-day dosing

Many peptides in this category respond better to training-day-only versus rest-day-included dosing. TB-500 with a ~2-3 days half-life of ~2-3 days is long-lived enough that daily dosing matters less than total exposure per cycle. The practical dosing schedule reflects this.

Body Composition / Training Applications

Workout Recovery

Workout Recovery responds to TB-500 with effect sizes proportional to training stimulus and nutritional adequacy. Users running aggressive caloric deficits see reduced response; users in surplus with adequate protein see proportionally larger response. Programming the inputs is half the protocol.

Strength

For strength, TB-500 integrates with training programming on a per-session and per-cycle basis. Training-day dosing produces stronger acute effect; rest-day inclusion supports sustained baseline. The protocol pattern reflects training intensity and recovery demand.

Lean Mass

The body composition community converges on TB-500 for lean mass with reported best-fit cycles of 8–12 weeks. Off-cycle of 4 weeks is standard. Stacking with complementary peptides on different pathways is the typical pattern for advanced users.

Endurance

Endurance responds to TB-500 with effect sizes proportional to training stimulus and nutritional adequacy. Users running aggressive caloric deficits see reduced response; users in surplus with adequate protein see proportionally larger response. Programming the inputs is half the protocol.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	SubQ	2-5 mg	8–12 weeks on / 4 weeks off
Conservative starter	SubQ	1-5 mg	4–6 weeks initial cycle
Body Composition focus	SubQ	2-5 mg	1-2x weekly SubQ (loading phase); maintenance lower
Maintenance phase	SubQ	1-5 mg	Ongoing with periodic pauses

Dose timing for TB-500 is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

TB-500 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from performance coaches and athletes.

TB-500 + IGF-1 LR3: Binds the IGF-1 receptor with full agonist activity. Pairs naturally with TB-500's mechanism in body composition / training protocols.
TB-500 + CJC-1295 + Ipamorelin Blend: CJC-1295 stimulates the GHRH receptor; ipamorelin stimulates the ghrelin/GHSR receptor. Pairs naturally with TB-500's mechanism in body composition / training protocols.
TB-500 + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with TB-500's mechanism in body composition / training protocols.
TB-500 + Tesamorelin + Ipamorelin Blend: Tesamorelin engages the GHRH receptor; ipamorelin engages the GHSR. Pairs naturally with TB-500's mechanism in body composition / training protocols.

Safety & Regulatory Status

WADA: Banned (S0) FDA: Unapproved Research: Preclinical + veterinary clinical (equine)

Generally well tolerated. Limited human safety data. Avoid in active cancer.

Lens-specific safety considerations for body composition / training use of TB-500: Generally well tolerated. Limited human safety data. Avoid in active cancer. Additional body composition / training monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

Thymosin β4 and tissue regeneration

PMID 19737543

Supporting

Thymosin β4 — actin sequestration and repair

PMID 22515427

TB-500 vs Related Peptides

Compound	Profile	Onset	Best For
TB-500	Synthetic thymosin β4 fragment	~2-3 days	Body Composition
IGF-1 LR3	Modified insulin-like growth factor 1	~20-30 hr (vs ~10 min for native IGF-1)	A modified IGF-1 with a 13-amino-acid N-terminal extension and Arg substitution that resists IGFBP binding — extending half-life from 10 minutes to roughly a day
Tesamorelin	Stabilised GHRH analogue	~30 min	An FDA-approved long-chain GHRH analogue used for HIV-associated lipodystrophy and notable for its consistent effect on visceral adipose reduction
Ipamorelin	Selective GHRP / ghrelin mimetic	~2 hr	The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite

Frequently Asked Questions

Should I cycle TB-500?

Standard cycle structure for body composition use is 8–12 weeks on, 4 weeks off. Continuous indefinite use is not advised for most compounds in this class; the off-period preserves dose response and reduces cumulative downregulation. Cycle stacking with complementary peptides is common in advanced protocols.

Best stack pairing for lean mass?

The canonical lean mass stack pairs TB-500 with a complementary GH-axis component, a connective-tissue support peptide, and — in advanced protocols — an anabolic-supportive component. Specific pairings depend on which dimension of body composition is prioritised: pure mass, mass-and-fat-loss, or recovery-focused.

Will TB-500 affect my training performance?

Most commonly via faster recovery between sessions, which permits higher training frequency and intensity. Acute performance-enhancing effects in a single session are not the typical profile. Users typically need to upregulate nutrition and adjust programming to take advantage of the increased recovery capacity.

Training-day only or daily dosing?

For most peptide compounds with short-to-moderate half-life, training-day dosing produces stronger acute effect; rest-day inclusion supports sustained baseline. The choice depends on the user's training volume and the compound's pharmacokinetics. Daily dosing for 4-7 days is the default; training-day-only protocols are appropriate for lower-volume programmes.

Will TB-500 actually increase lean mass?

TB-500's effect on body composition depends on which dimension of the anabolic cascade it engages. Direct anabolic pathway engagement is not the principal mechanism, but contributions to recovery, connective tissue, and inflammatory tone produce measurable body-composition shifts in trained users. Effect size is proportional to training stimulus and nutritional adequacy.

What route should I use for TB-500?

TB-500 is delivered by subq/im. Subcutaneous administration is standard for ${o.cat.toLowerCase()} class peptides and provides reliable systemic bioavailability. The choice depends on target system and convenience.

Clinical Protocol

Start a TB-500 Protocol

Alukard provides physician-supervised body composition protocols with GMP-certified TB-500 and GMP-certified compounds and training-aware dosing guidance.

Get Protocol

Quick Facts

Molecular weight: 888-1717 Da (depending on form)
Sequence length: 17 aa
Half-life: ~2-3 days
WADA: Banned (S0)
FDA: Unapproved
Research: Preclinical + veterinary clinical (equine)

Stack Partners

IGF-1 LR3

CJC-1295 + Ipamorelin Blend

BPC-157

Tesamorelin + Ipamorelin Blend

Research Note

All body composition / training applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for TB-500 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised body composition protocols

Start Your Body Composition / Training Protocol for TB-500

Alukard provides physician-supervised body composition protocols with GMP-certified compounds and training-aware dosing guidance.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised